CEPI has opened a call for proposals to rapidly develop and manufacture a proven vaccine approach that can be used against 2019-nCoV. The call is open for two weeks until mid-February. Applications are open worldwide to all types of non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and
PHEP Recipient Monthly Conference Call Scheduled for February 19 CDC’s next monthly conference call with PHEP recipients will be held from 3 p.m. to 4 p.m. EDT on Wednesday, February 19. Participant information is provided below. Conference Call Information Bridge Line: (888) 566-1873 Participant Code: 3358383 The Public Health Emergency Preparedness (PHEP) cooperative
Target Audience: Health care providers (including primary care physicians & nursing professionals) Key Note Speakers: Dr. Gerald Evans Chair of the Division of Infectious Diseases, Professor of Medicine, Queens University; Attending Staff, Kingston Health Sciences Centre Dr. Piotr Oglaza Medical Officer of Health & CEO, Hastings Prince Edward Public Health Yvonne DeWit, Epidemiologist, Hastings Prince
The capability to provide unburdened chem-bio protection will maximize time on target for the warfighter and the stability operator, provide operational flexibility, extend mission duration, and enable military operations in austere environments regardless of the threat. PPB will consist of lightweight materials that protect the warfighter from exposure to any CB threat while simultaneously providing
The Centers for Disease Control and Prevention (CDC) is closely monitoring an outbreak caused by a novel (new) coronavirus in Wuhan City, Hubei Province, China. A number of countries, including the U.S., are actively screening incoming travelers from Wuhan. Starting January 21, 2020, CDC’s 2019 Novel Coronavirus (2019-nCoV) response team will host a series of national
A U.S. Trans-Agency Scientific Meeting on Developing Medical Countermeasures to Treat Acute and Chronic Effects of Ocular Chemical Toxicity will be held Feb 25-26, 2020 at the NIAID Conference Center in Rockville, Md. This meeting, sponsored by the NIH Chemical Countermeasures Research Program (CCRP) and organized in collaboration with the National Eye Institute (HHS/NIH/NEI) and
A planning committee of the National Academies of Sciences, Engineering, and Medicine will conduct a one day workshop on Feb 26, 2020 to bring together stakeholders to discuss potential ethical issues that may arise from new and emerging trends in biomedical research (including behavioral and social research) and society. The workshop will identify a range
The House Foreign Affairs Subcommittee on Asia, the Pacific, and Nonproliferation will hold a second subcommittee hearing on the coronavirus outbreak on 27 Feb 2020 at 2:00 Eastern. Witnesses will include U.S. government officials who have led the response to the virus. Date: Thursday, February 27, 2020 Time: 2:00 p.m. EST Subject: Coronavirus Disease 2019: The U.S. and
HHS-NIH-NIAID-BAA2020-1 Research Area 002: Advanced Development of Vaccine Candidates for Acute Flaccid Myelitis (AFM) Associated With Enterovirus D68 Supports the development of inactivated Enterovirus D68 vaccines, preferably using adjuvants that minimize regulatory concerns and expedite vaccine development into a Phase I clinical trial. Due Date: February 28, 2020, by 3 p.m. Eastern Time Learn more
